Laser Ablation for Benign and Malignant Thyroid Nodules - A Mini-Literature Review

Overview

Journal Endocr Metab Immune Disord Drug Targets

Publisher Bentham Science Publishers

Specialties Allergy & Immunology
Endocrinology
Infectious Diseases
Pharmacology

Date 2023 Oct 20

PMID 37861031

Authors

Roberto Negro

Affiliations

Soon will be listed here.

Abstract

Background: Thyroid nodules are a common disease in endocrine clinical practice. They are often benign, asymptomatic, and do not require any treatment. But, in a non-negligible proportion, they can cause local symptoms of compression or esthetic concerns. In the last two decades, the advent of laser ablation (LA) has become a valid alternative to surgery for these nodules. Moreover, LA has also been successfully used to treat small thyroid cancers and neck recurrence.

Objective: This study aims to review and summarize the published literature regarding LA in the treatment of benign and malignant thyroid nodules.

Methods: A comprehensive literature search on PubMed from 2000 to 2023 was carried out. The search terms included: thyroid, nodules, laser, cancer, lymph node metastasis, and autonomously functioning nodules. The most relevant investigations in the field were selected.

Results: In the last two decades, a very remarkable number of papers consistently demonstrated that LA is able to durably shrink benign nodules on average by about 50%; better results are obtained in spongiform nodules with a volume less than 15 ml; 500 J/ml of tissue should be administered. LA may be a valid option to treat autonomously functioning nodules and papillary thyroid cancers especially if they are <10 mm, and with neck recurrence in patients already submitted to surgery. LA has also been demonstrated to be cost-effective compared to surgical treatment both in benign and malignant lesions, with similar outcomes.

Conclusion: Evidence demonstrated that LA is a valid alternative to surgery in benign and malignant thyroid lesions, but also to obtain a successful treatment, a careful selection of the lesion is mandatory.

References

Knudsen N, Perrild H, Christiansen E, Rasmussen S, Dige-Petersen H, Jorgensen T . Thyroid structure and size and two-year follow-up of solitary cold thyroid nodules in an unselected population with borderline iodine deficiency. Eur J Endocrinol. 2000; 142(3):224-30. DOI: 10.1530/eje.0.1420224. View

Reiners C, Wegscheider K, Schicha H, Theissen P, Vaupel R, Wrbitzky R . Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid. 2005; 14(11):926-32. DOI: 10.1089/thy.2004.14.926. View

Kwong N, Medici M, Angell T, Liu X, Marqusee E, Cibas E . The Influence of Patient Age on Thyroid Nodule Formation, Multinodularity, and Thyroid Cancer Risk. J Clin Endocrinol Metab. 2015; 100(12):4434-40. PMC: 4667162. DOI: 10.1210/jc.2015-3100. View

Durante C, Costante G, Lucisano G, Bruno R, Meringolo D, Paciaroni A . The natural history of benign thyroid nodules. JAMA. 2015; 313(9):926-35. DOI: 10.1001/jama.2015.0956. View

Negro R . What happens in a 5-year follow-up of benign thyroid nodules. J Thyroid Res. 2014; 2014:459791. PMC: 4236885. DOI: 10.1155/2014/459791. View

Papini E, Hegedus L . Minimally Invasive Ablative Treatments for Benign Thyroid Nodules: Current Evidence and Future Directions. Thyroid. 2023; 33(8):890-893. DOI: 10.1089/thy.2023.0263. View

Mauri G, Gennaro N, Lee M, Baek J . Laser and radiofrequency ablations for benign and malignant thyroid tumors. Int J Hyperthermia. 2019; 36(2):13-20. DOI: 10.1080/02656736.2019.1622795. View

Trimboli P, Castellana M, Piccardo A, Romanelli F, Grani G, Giovanella L . The ultrasound risk stratification systems for thyroid nodule have been evaluated against papillary carcinoma. A meta-analysis. Rev Endocr Metab Disord. 2020; 22(2):453-460. PMC: 8087557. DOI: 10.1007/s11154-020-09592-3. View

Cecoli F, Ceresola E, Altrinetti V, Cabria M, Cappagli M, Montepagani A . Therapeutic Strategies and Clinical Outcome in Papillary Thyroid Microcarcinoma: A Multicenter Observational Study. Eur Thyroid J. 2016; 5(3):180-186. PMC: 5091244. DOI: 10.1159/000446746. View

10.

Mansouri V, Arjmand B, Rezaei Tavirani M, Razzaghi M, Rostami-Nejad M, Hamdieh M . Evaluation of Efficacy of Low-Level Laser Therapy. J Lasers Med Sci. 2021; 11(4):369-380. PMC: 7736953. DOI: 10.34172/jlms.2020.60. View

11.

Papini E, Bizzarri G, Pacella C . Percutaneous laser ablation of benign and malignant thyroid nodules. Curr Opin Endocrinol Diabetes Obes. 2008; 15(5):434-9. DOI: 10.1097/MED.0b013e32830eb89a. View

12.

Mauri G, Cova L, Monaco C, Sconfienza L, Corbetta S, Benedini S . Benign thyroid nodules treatment using percutaneous laser ablation (PLA) and radiofrequency ablation (RFA). Int J Hyperthermia. 2016; 33(3):295-299. DOI: 10.1080/02656736.2016.1244707. View

13.

Ridouani F, Tuttle R, Ghosn M, Li D, Wong R, Fagin J . Ultrasound-Guided Percutaneous Laser Ablation of the Thyroid Gland in a Swine Model: Comparison of Ablation Parameters and Ablation Zone Dimensions. Cardiovasc Intervent Radiol. 2021; 44(11):1798-1806. PMC: 9578502. DOI: 10.1007/s00270-021-02915-0. View

14.

Gambelunghe G, Fede R, Bini V, Monacelli M, Avenia N, DAjello M . Ultrasound-guided interstitial laser ablation for thyroid nodules is effective only at high total amounts of energy: results from a three-year pilot study. Surg Innov. 2012; 20(4):345-50. DOI: 10.1177/1553350612459276. View

15.

Papini E, Monpeyssen H, Frasoldati A, Hegedus L . 2020 European Thyroid Association Clinical Practice Guideline for the Use of Image-Guided Ablation in Benign Thyroid Nodules. Eur Thyroid J. 2020; 9(4):172-185. PMC: 7445670. DOI: 10.1159/000508484. View

16.

Pacella C, Bizzarri G, Guglielmi R, Anelli V, Bianchini A, Crescenzi A . Thyroid tissue: US-guided percutaneous interstitial laser ablation-a feasibility study. Radiology. 2000; 217(3):673-7. DOI: 10.1148/radiology.217.3.r00dc09673. View

17.

Papini E, Guglielmi R, Bizzarri G, Pacella C . Ultrasound-guided laser thermal ablation for treatment of benign thyroid nodules. Endocr Pract. 2004; 10(3):276-83. DOI: 10.4158/EP.10.3.276. View

18.

Papini E, Guglielmi R, Bizzarri G, Graziano F, Bianchini A, Brufani C . Treatment of benign cold thyroid nodules: a randomized clinical trial of percutaneous laser ablation versus levothyroxine therapy or follow-up. Thyroid. 2007; 17(3):229-35. DOI: 10.1089/thy.2006.0204. View

19.

Valcavi R, Riganti F, Bertani A, Formisano D, Pacella C . Percutaneous laser ablation of cold benign thyroid nodules: a 3-year follow-up study in 122 patients. Thyroid. 2010; 20(11):1253-61. DOI: 10.1089/thy.2010.0189. View

20.

Papini E, Rago T, Gambelunghe G, Valcavi R, Bizzarri G, Vitti P . Long-term efficacy of ultrasound-guided laser ablation for benign solid thyroid nodules. Results of a three-year multicenter prospective randomized trial. J Clin Endocrinol Metab. 2014; 99(10):3653-9. DOI: 10.1210/jc.2014-1826. View